Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes Injectable medication that combines the effects of GLP-1 and GIP hormones for the treatment of type 2 diabetes CONCENTRATION CONCENTRATION CONCENTRATION CONCENTRATION CONCENTRATION Tirzepatide Tirzepatide Tirzepatide Tirzepatide Tirzepatide 60mg/3mL 60mg/3mL 60mg/3mL 60mg/3mL PHARMACEUTICAL FORM PHARMACEUTICAL FORM PHARMACEUTICAL FORM PHARMACEUTICAL FORM PHARMACEUTICAL FORM Injectable solution Injectable solution Injectable solution Injectable solution Injectable solution 1 vial 60 mg of Tirzepatide (Lyophilized Powder) 1 vial 3 ml of bacteriostatic water 1 vial 60 mg of Tirzepatide (Lyophilized Powder) 1 vial 3 ml of bacteriostatic water Efficacy Tirzepatide is a dual agonist of the GIP and GLP-1 receptors, designed to enhance glycemic control in patients with type 2 diabetes
Cancer risk with GLP-1 receptor agonists: meta-analysis of randomized controlled trials
Every dose tier
Switching medications Your body may respond better to a different mechanism, especially if youre experiencing side effects
Peptide degradation is silent
This is vital for patients who frequently travel or are on vacation
